期刊文献+

二藤通痹合剂抗类风湿有效部位药效学筛选

Pharmaceutical Screening of Effective Fraction of Erteng Tongbi Mixture
下载PDF
导出
摘要 目的:对二藤通痹合剂进行有效部位提取,并以抗类风湿药理作用验证其合理性,筛选出最优提取部位。方法:制作大鼠关节炎模型(AA模型),以各组提取液灌胃给药,测量大鼠足肿胀度,测定血清细胞因子白介素-2(IL-2)、白介素-6(IL-6),并取后肢关节做病理组织学检查。结果:二藤提取液Ⅰ、Ⅱ、Ⅲ组均对大鼠足肿胀有消炎消肿作用,其中Ⅱ组与模型组比较有统计学意义(P<0.01);二滕提取液Ⅱ、Ⅲ组有减轻关节滑膜病变、减轻关节软骨病变作用(P<0.01);二藤提取液Ⅰ、Ⅲ组能降低AA大鼠血中IL-2、IL-6水平。结论:优选组分Ⅲ为最佳提取液。 Objective : To select the best extractive fraction of Ertong Tongbi Mixtrue ( ETM ), the effective parts of ETM was extracted and thier rationality was proved by pharmacological tests on anti-theumatioid. Methods : The extractive was divided into three groups( Ⅰ , Ⅱ and Ⅲ ). Rat arthritis model(AA modle) was made. The rat was infused by intragastric garage with different groups of extractive, the degree of rat foot swelling was measured, the level of cytokine IL - 2 and IL- 6 in serum was tested, and the change of joints was checked by Pathological and histlolgy. Results :All extractive groups on foot swelling can mitigate inflammation and edema. The effects of group Ⅱ is gisnificantly compare to model group( P 〈 0.01 ). The effects of groups Ⅱ and Ⅲ on releasing synovial membrane arthropathy and cartilage injuring are remarkable( P 〈 0.01 ). The groups Ⅰ and Ⅲ can decrease the level of IL - 2 and IL - 6 in serum of AA rat. Conclusion :The best extractive is group Ⅲ.
出处 《中华中医药学刊》 CAS 2008年第11期2481-2483,共3页 Chinese Archives of Traditional Chinese Medicine
基金 广州中医药大学中医药科研基金资助项目(200443)
关键词 二藤通痹合剂 大鼠关节炎模型 足肿胀度 白介素-2 白介素-6 病理检查 ertong tongbi mixtrue rat arthritis model foot swelling IL - 2 IL - 6 pathological examination
  • 相关文献

参考文献4

二级参考文献11

  • 1严泽群,胡幼华,朱晓晴,谭仁祥.甘青蒿化学成分研究[J].中草药,1993,24(11):567-569. 被引量:9
  • 2刘晓玲,陈光星,赵诗哲,刘清平,黄可儿,陈纪藩.二藤合剂氯仿提取物对类风湿性关节炎T细胞的免疫调节作用[J].广州中医药大学学报,2005,22(3):206-209. 被引量:5
  • 3刘锡癸,中草药,1993年,24卷,8期,395页
  • 4团体著者,植物药有效成分手册,1983年
  • 5林启寿,中草药成分化学,1977年
  • 6团体著者,中药大辞典,1977年
  • 7Vander Linden S, Valkenburg HA, Cats A. Evaluation of dagnostic criteria for ankylosing spondylitis [J] .Arthritis Rheum, 1984, 27:361.
  • 8Armet FC, Eoworthy SM, Block BA, et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis[J]. Arthritis Rheum, 1988, 31 (3): 315 - 319.
  • 9Hauselmarm HJ. Mechanisms of cautilage destruction and novel nonsurgical therapeutic strategies to retard cartilage injury in rheumatoid arthritis[J]. Curr Opin Rheumatol, 1997, 9(3): Z41.
  • 10Lorenz HM. T-cell-activation inhibitors in rheumatoid arthritis[J].Bio Drugs, 2003, 17(4): 263.

共引文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部